Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M‐protein, and skin changes) syndrome

Información

DOI:
https://doi.org/10.1002/14651858.CD006828.pub3Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 13 junio 2012see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Neuromuscular

Copyright:
  1. Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Satoshi Kuwabara

    Correspondencia a: Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan

    [email protected]

  • Angela Dispenzieri

    Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, USA

  • Kimiyoshi Arimura

    Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

  • Sonoko Misawa

    Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan

  • Chiaki Nakaseko

    Department of Hematology, Chiba University Hospital, Chiba, Japan

Contributions of authors

Satoshi Kuwabara and Angela Dispenzieri wrote the review, which was critically reviewed and amended by Sonoko Misawa, Kimiyoshi Arimura, and Chiaki Nakaseko.

Sources of support

Internal sources

  • Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.

  • Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.

  • Department of Neurology and Geriatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

External sources

  • No sources of support supplied

Declarations of interest

Chiaki Nakaseko, Satoshi Kuwabara, Kimiyoshi Arimura, Sonoko Misawa: none known

Angela Dispenzieri: grants paid to her institution for clinical trials (Celgene, Johnson & Johnson) or to discuss future protocols (Onyx, Millenium). She has received financial support for travel to deliver a lecture from Binding Site. She states that none of these interactions affect the content of the present review.

Acknowledgements

We are grateful to Yasunori Sato for statistical advice.

The editorial base of the Cochrane Neuromuscular Disease Group is supported by the the MRC Centre for Neuromuscular Diseases.

Version history

Published

Title

Stage

Authors

Version

2012 Jun 13

Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M‐protein, and skin changes) syndrome

Review

Satoshi Kuwabara, Angela Dispenzieri, Kimiyoshi Arimura, Sonoko Misawa, Chiaki Nakaseko

https://doi.org/10.1002/14651858.CD006828.pub3

2008 Oct 08

Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M‐protein, and skin changes) syndrome

Review

Satoshi Kuwabara, Angela Dispenzieri, Kimiyoshi Arimura, Sonoko Misawa

https://doi.org/10.1002/14651858.CD006828.pub2

2007 Oct 17

Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M‐protein, and skin changes) syndrome

Protocol

Satoshi Kuwabara, Angela Dispenzieri, Kimiyoshi Arimura, Sonoko Misawa

https://doi.org/10.1002/14651858.CD006828

Differences between protocol and review

We revised the methods section to reflect updated Cochrane 'Risk of bias' methodology.